124 related articles for article (PubMed ID: 36507826)
21. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
22. Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.
Young AL; Chalmers CR; Hawcroft G; Perry SL; Treanor D; Toogood GJ; Jones PF; Hull MA
BMC Cancer; 2013 Feb; 13():92. PubMed ID: 23442768
[TBL] [Abstract][Full Text] [Related]
23. 470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
Mo S; Ku HJ; Choi SH; Jeong HJ; Park DG; Oh MH; Ahn JC
Anticancer Res; 2021 Mar; 41(3):1407-1420. PubMed ID: 33788732
[TBL] [Abstract][Full Text] [Related]
24. Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E
Moltu K; Henjum K; Oberprieler NG; Bjørnbeth BA; Taskén K
Hum Immunol; 2017 Feb; 78(2):129-137. PubMed ID: 27769746
[TBL] [Abstract][Full Text] [Related]
25. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
[TBL] [Abstract][Full Text] [Related]
26. STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression.
Wang JY; Sun J; Huang MY; Wang YS; Hou MF; Sun Y; He H; Krishna N; Chiu SJ; Lin S; Yang S; Chang WC
Oncogene; 2015 Aug; 34(33):4358-67. PubMed ID: 25381814
[TBL] [Abstract][Full Text] [Related]
27. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
[TBL] [Abstract][Full Text] [Related]
28. Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.
Pereira C; Queirós S; Galaghar A; Sousa H; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
PLoS One; 2014; 9(4):e92000. PubMed ID: 24694755
[TBL] [Abstract][Full Text] [Related]
29. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
30. Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2.
Löffler I; Grün M; Böhmer FD; Rubio I
BMC Cancer; 2008 Dec; 8():380. PubMed ID: 19099561
[TBL] [Abstract][Full Text] [Related]
31. A RIPK3-PGE
Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y
Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671
[TBL] [Abstract][Full Text] [Related]
32. Leukemia inhibitory factor signaling in Xenopus embryo: Insights from gain of function analysis and dominant negative mutant of the receptor.
Jalvy S; Veschambre P; Fédou S; Rezvani HR; Thézé N; Thiébaud P
Dev Biol; 2019 Mar; 447(2):200-213. PubMed ID: 30578761
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
34. Reviving human γδT cells from apoptosis induced by IL-12/18 via p-JNK inhibition.
Song Y; Teo HY; Liu Y; Zhang X; Chen J; Zhang Y; Liu H
J Leukoc Biol; 2022 Dec; 112(6):1701-1716. PubMed ID: 35770879
[TBL] [Abstract][Full Text] [Related]
35. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
Doherty GA; Byrne SM; Molloy ES; Malhotra V; Austin SC; Kay EW; Murray FE; Fitzgerald DJ
BMC Cancer; 2009 Jun; 9():207. PubMed ID: 19558693
[TBL] [Abstract][Full Text] [Related]
36. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
[TBL] [Abstract][Full Text] [Related]
37. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gammadeltaT cells isolated from glioblastoma patients.
Yamaguchi T; Suzuki Y; Katakura R; Ebina T; Yokoyama J; Fujimiya Y
Cancer Immunol Immunother; 1998 Oct; 47(2):97-103. PubMed ID: 9769118
[TBL] [Abstract][Full Text] [Related]
39. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4.
Jeong JW; Park C; Cha HJ; Hong SH; Park SH; Kim GY; Kim WJ; Kim CH; Song KS; Choi YH
BMB Rep; 2018 Oct; 51(10):532-537. PubMed ID: 30269738
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
